|
|
|
|
|
LOS ANGELES, CA, Feb 26, 2022 - (ACN Newswire) - Allied Energy, Inc (OTC: AGGI) has won control of a majority stake in WeLife Technology Corp via a tender for the company's shares, whose acceptance period closed on February 25, 2022.
WeLife Technology Corp is a biotech company with at least five products globally generating millions in sales. Its chief scientist is Dr Michael Borkin, who has developed an international reputation for his extensive research and clinical experience in the areas of life extension and anti-aging.
Dr Borkin's emphasis on endocrine and neuro-transmitter regulation led to the development of unique non-invasive diagnostic and treatment protocols that dramatically increases both patient acceptance and treatment success rates.
With more than 70 supplements formulated by Dr Borkin marketed worldwide, and having an unparalleled reputation, Dr Borkin sets a Gold Standard within the Nutraceutical Industry, and continues to innovate new technologies and produce advanced protocols to slow and reverse the Ageing Process.
Dr Michael Borkin
Co-Founder, Sabre Sciences and Endoscreen Laboratories
Chief Scientist, WeLife Technology Corporation
Considered the "Father of Naturopathic Endocrinology", Dr. Borkin was responsible for establishing the board specialty and authored the first National Board in Endocrinology for the American Naturopathic Medical Certification & Accreditation Board in Washington, DC.
In 1986 he began development of a transdermal delivery system designed to deliver hormones and nutraceuticals through the skin. In 1998 he co-founded Sabre Sciences and Endoscreen Laboratories to prove efficacy for this novel delivery system.
He was appointed president of the California State Naturopathic Medical Association in 1993 and served until 1997. In 2002 Dr. Borkin was inducted into the Alternative Medicine Hall of Fame, making him the youngest inductee ever so honored.
Dr. Borkin's patients have included Heads of State, Religious leaders, and Celebrities and Athletic Icons. Now dedicated full time to research and teaching, he has more than 36 years of clinical experience, which he shares with medical researchers around the globe. He currently has teaching facilities in San Diego, California; Coronado, Panama; St. Petersburg, Russia and Nice, France.
About WeLife Technology Corp
WeLife Technology Corp., establish in 2018, is a biotechnology and human health product development and marketing company. For more information, visit https://welifeus.com/home/index.
About Allied Energy, Inc
Allied Energy, Inc. (OTCMKTS: AGGI) operates as an independent oil and natural gas exploration and development company operating in the continental United States. Please visit https://www.alliedenergy.com.
Topic: Management Change
Source: WeLife Tech Corp
Sectors: Healthcare & Pharm
http://www.acnnewswire.com
From the Asia Corporate News Network
Copyright © 2026 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
|
|
|
|
|
|
Latest Press Releases
Slovak-Japanese Animated Film "Angel & Meow" Wins Prestigious Crystal Pine Award, Decided by an Oscar and BAFTA-Winning Jury 
June 9, 2026 08:00 HKT/SGT
|
|
|
GA-ASI Announces Investments in Six Dutch Companies
June 9, 2026 00:00 HKT/SGT
|
|
|
Mazda Advances Toward Commercialization of Onboard CO2 Capture System
Monday, June 8, 2026 11:03:00 PM
|
|
|
Collaboration Between OCTARVIA Programs and MiPoLin(R)
Monday, June 8, 2026 10:34:00 PM
|
|
|
Hitachi joins Anthropic's "Project Glasswing" an AI-powered security program
Monday, June 8, 2026 10:04:00 PM
|
|
|
Hitachi and Intel announce strategic collaboration to accelerate AI transformation across key industries
Monday, June 8, 2026 9:38:00 PM
|
|
|
TON Corporation to Launch 'TonTV', a Telegram-Native Short-Drama Platform, Globally in September 2026
June 8, 2026 21:00 HKT/SGT
|
|
|
CMS's (867.HK/8A8.SG) Self-developed Innovative INHBE-Targeting siRNA Drug CMS-D008 Presents Its Preclinical Results at the ADA Scientific Sessions
June 8, 2026 19:30 HKT/SGT
|
|
|
Everest Medicines Enters into Asset Purchase Agreement with Corxel Pharmaceuticals to Develop and Commercialize LNZ100 in Greater China, Strengthen Presence in Ophthalmology
June 8, 2026 18:12 HKT/SGT
|
|
|
Focus Graphite Completes Air Quality Assessment for the Lac Knife Project; Advancing Towards ESIA Completion
June 8, 2026 17:29 HKT/SGT
|
|
|
|
|
More Press release >> |
|
 |
|
 |
|
